We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Novel T-Cell Test for SARS-CoV-2 Can Help Monitor Cellular Immunity Against COVID-19

By LabMedica International staff writers
Posted on 21 Jul 2021
Print article
Illustration
Illustration
A novel T-cell test for SARS-CoV-2 can help monitor cellular immunity against COVID-19 and offers greater detail to the immune status of long-haul patients.

Infectolab Americas (Oakdale, MN, USA) has validated a novel T-cell test for COVID-19 that uses technology based on stimulating antigen specific T-cells in vitro and enumerating the antigen specific T-cells to a given antigen. Studies on antigen specific SARS-CoV-2 T-cells have shown that testing for Interferon-γ and IL-2 release can provide important information about cellular immunity post-infection and vaccine efficacy. Recent studies have shown that six months post-infection Interferon-γ and IL-2 producing antigen specific T-cells were present in the patients. They showed that the severity of the disease appears to have played a role in the number of T-cells present six months post-disease.

The mRNA vaccine study conducted by Infectolab showed that three months post-mRNA vaccine antigen specific central memory T-cells and antigen specific TH-1 T-cells were present in the participants’ blood, indicating the potential of a long-term cellular memory response to the vaccine.

Infectolab’s SARS-CoV-2 T-cell test provides an insight into the T-cells of COVID-19 patients and vaccinated individuals. The test has 3-4-day turnaround time and offers comprehensive reporting that gives information about the amount of SARS-CoV-2 antigen specific TH-1 T-cells and central memory T-cells. Having a quick T-cell test available for COVID-19 infected patients and also a test where vaccinated people can find out how likely it is that they have developed cellular immunity in addition to humoral immunity, can help guide treatment and ease many concerns.

“The pandemic has been an extremely challenging time for all of us and Infectolab Americas is proud to be able to introduce a neat tool like this, that can help give us a better understanding of the immune system response to the infection and the vaccination for COVID-19,” said Dr. Felix Scholz, PhD, President of Infectolab Americas.

Related Links:
Infectolab Americas

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
COVID-19 Rapid Test
AQ+ COVID-19 Ag Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.